Early adversity leads to accelerated brain development with long-term risks

A study led by researchers from A*STAR’s Singapore Institute for Clinical Sciences (SICS) has found evidence suggesting that children exposed to elevated levels of early life adversity (ELA) exhibit an accelerated pattern of brain development during the preschool years.

Diffusion Pharma’s stockholders support merger with EIP Pharma – Pharmaceutical Technology

Diffusion Pharma’s stockholders have agreed to its merger with EIP Pharma, creating a combined company focused on neurodegenerative disorders. Image Credit: Shutterstock / LightField Studios

August 16, 2023

Pharmalittle: We’re reading about FDA guidance on AI, meds releasing ‘forever chemicals,’ and more

Top of the morning to you, and a fine one it is, although we concede this may depend on your tolerance for frigid temperatures. Nonetheless,

January 7, 2025

Pharmalittle: We’re reading about MorphoSys drug risks, an AstraZeneca admission, and more

Good morning, everyone, and welcome to another working week. We hope the weekend respite was invigorating and inspiring, because that oh-too predictable routine of online

April 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.